AI-powered, non-invasive early breast cancer screening
Book a personalized demo with our team.
Niramai’s AI-driven diagnostics platform enhances breast health screening by combining thermal imaging with proprietary machine learning algorithms to deliver accurate, automated assessments. The solution is portable, privacy-aware, and can be deployed in clinics, hospitals, and screening camps, helping detect cancer earlier even in younger women or dense breast tissue where mammography may underperform. Niramai’s flagship device SMILE-100 has received US FDA clearance, and the Thermalytix technology holds multiple patents and international approvals. The company also offers home screening services and partnership models for broader outreach.
Healthcare providers, Hospitals & clinics, Diagnostic centres, Public health programs, Women’s health advocates
Bengaluru, India
51-200 employees
No reviews yet
Be the first to share your experience!
